BERKELEY, Calif., Oct. 6, 2026 – Ray Therapeutics (RayTx) congratulates Drs. Karl Deisseroth, Peter Hegemann, and Georg Nagel on receiving the 2026 Nobel Prize in

CIRM Funding will support the ongoing Phase 1/2 clinical trial and manufacturing activities to prepare RTx-021 for late-stage development

Accomplished biopharma leader brings formidable experience advancing rare disease companies from clinical development to commercial readiness